HROW - Harrow Health Q4 2023 Earnings Preview
2024-03-18 17:35:14 ET
More on Harrow Health
- Harrow's Drug Iheezo Is Off To A Great Start
- Harrow: Hedge Downside Risk With The 11.5% Yielding Baby Bonds
- Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity
- Harrow says dry eye drug Vevye now available in US
- Seeking Alpha’s Quant Rating on Harrow Health